Combination therapy associating preferably a ceramide with a cytotoxic drug

Details for Australian Patent Application No. 2005303389 (hide)

Owner Yissum Research Development Company of the Hebrew University of Jerusalem

Inventors Khazanov, Elena; Barenholz, Yechezkel

Agent Griffith Hack

Pub. Number AU-A-2005303389

PCT Pub. Number WO2006/051549

Priority 60/627,281 15.11.04 US

Filing date 15 November 2005

Wipo publication date 18 May 2006

International Classifications

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 31/132 (2006.01) - having two or more amino groups, e.g. spermidine, putrescine

A61K 31/704 (2006.01)

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/051549 Priority application(s): WO2006/051549

7 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005303398-Method for priority based queuing and assembling of packets

2005303388-Blood type method system and device